MiR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42

Biochemical and Biophysical Research Communications

Volumn 431, Issue 3, 2013, Pages 560-565

  Li, Yuefeng ^a   Zhu, Xiaolan ^b   Xu, Wenlin ^b   Wang, Dongqing ^a   Yan, Jinchuan ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b The Fourth Affiliated Hospital of Jiangsu University   (China)

Author keywords

Cdc42; Colorectal cancer; MiR 330

Indexed keywords

GUANOSINE TRIPHOSPHATASE; MICRORNA; MICRORNA 330; PROTEIN CDC42; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; COLORECTAL CANCER; DOWN REGULATION; DOWNSTREAM PROCESSING; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE TARGETING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; UPREGULATION;

ANIMALS; APOPTOSIS; CDC42 GTP-BINDING PROTEIN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICRORNAS; NEOPLASM TRANSPLANTATION;

EID: 84873745294     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.016     Document Type: Article

References (33)

1. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 2009, 10:126-139.
2. Mi S., Lu J., Sun M., Li Z., Zhang H., Neilly M.B., Wang Y., Qian Z., Jin J., Zhang Y., Bohlander S.K., Le Beau M.M., Larson R.A., Golub T.R., Rowley J.D., Chen J. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 2007, 104:19971-19976.
3. Lee K.H., Chen Y.L., Yeh S.D., Hsiao M., Lin J.T., Goan Y.G., Lu P.J. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Oncogene 2009, 28:3360-3370.
4. Pang Y., Young C.Y., Yuan H. MicroRNAs and prostate cancer. Acta Biochim. Biophys. Sin. (Shanghai) 2010, 42:363-369.
5. Hodzic J., Giovannetti E., Calvo B.D., Adema A.D., Peters G.J. Regulation of deoxycytidine kinase expression and sensitivity to gemcitabine by micro-RNA 330 and promoter methylation in cancer cells. Nucleosides Nucleotides Nucleic Acids 2011, 30:1214-1222.
6. Ruike Y., Ichimura A., Tsuchiya S., Shimizu K., Kunimoto R., Okuno Y., Tsujimoto G. Global correlation analysis for micro-RNA and mRNA expression profiles in human cell lines. J. Hum. Genet. 2008, 53:515-523.
7. Jeyapalan Z., Deng Z., Shatseva T., Fang L., He C., Yang B.B. Expression of CD44 3'-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucleic Acids Res. 2011, 39:3026-3041.
8. Machesky L.M., Hall A. Rho: a connection between membrane receptor signalling and the cytoskeleton. Trends Cell Biol. 1996, 6:304-310.
9. Stengel K., Zheng Y. Cdc42 in oncogenic transformation, invasion, and tumorigenesis. Cell. Signal. 2011, 23:1415-1423.
10. Yang L., Wang L., Zheng Y. Gene targeting of Cdc42 and Cdc42GAP affirms the critical involvement of Cdc42 in filopodia induction, directed migration, and proliferation in primary mouse embryonic fibroblasts. Mol. Biol. Cell 2006, 17:4675-4685.
11. Sahai E., Marshall C.J. RHO-GTPases and cancer. Nat. Rev. Cancer 2002, 2:133-142.
12. Fritz G., Just I., Kaina B. Rho GTPases are over-expressed in human tumors. Int. J. Cancer 1999, 81:682-687.
13. Wang M., Liu Y., Liu S., Wang E. Abnormal expression of p120-catenin and E-cadherin is significantly correlated with malignant phenotype of human lung cancer. Zhongguo Fei Ai Za Zhi 2009, 12:306-311.
14. Prendergast G.C. Actin' up: RhoB in cancer and apoptosis. Nat. Rev. Cancer 2001, 1:162-168.
15. Zugasti O., Rul W., Roux P., Peyssonnaux C., Eychene A., Franke T.F., Fort P., Hibner U. Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt. Mol. Cell. Biol. 2001, 21:6706-6717.
16. Kovalchuk O., Filkowski J., Meservy J., Ilnytskyy Y., Tryndyak V.P., Chekhun V.F., Pogribny I.P. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol. Cancer Ther. 2008, 7:2152-2159.
17. Zhu X., Shen H., Li H., Long L., Hui L., Xu W. miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6. FEBS Lett. 2013, 587:73-81.
18. Li Y., Guessous F., Zhang Y., Dipierro C., Kefas B., Johnson E., Marcinkiewicz L., Jiang J., Yang Y., Schmittgen T.D., Lopes B., Schiff D., Purow B., Abounader R. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009, 69:7569-7576.
19. Zhu X., Li H., Long L., Hui L., Chen H., Wang X., Shen H., Xu W. MiR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A. Acta Biochim. Biophys. Sin. (Shanghai) 2012, 44:519-526.
20. Gomez Del Pulgar T., Valdes-Mora F., Bandres E., Perez-Palacios R., Espina C., Cejas P., Garcia-Cabezas M.A., Nistal M., Casado E., Gonzalez-Baron M., Garcia-Foncillas J., Lacal J.C. Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism. Int. J. Oncol. 2008, 33:185-193.
21. Qing H., Gong W., Che Y., Wang X., Peng L., Liang Y., Wang W., Deng Q., Zhang H., Jiang B. PAK1-dependent MAPK pathway activation is required for colorectal cancer cell proliferation. Tumor Biol. 2012, 33:985-994.
22. Anaya D.A., Chang G.J., Rodriguez-Bigas M.A. Extracolonic manifestations of hereditary colorectal cancer syndromes. Clin. Colon Rectal Surg. 2008, 21:263-272.
23. Cooper K., Squires H., Carroll C., Papaioannou D., Booth A., Logan R.F., Maguire C., Hind D., Tappenden P. Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol. Assess. 2010, 14:1-206.
24. Jin K., Gao W., Lu Y., Lan H., Teng L., Cao F. Mechanisms regulating colorectal cancer cell metastasis into liver (Review). Oncol. Lett. 2012, 3:11-15.
25. Shah A.A., Leidinger P., Blin N., Meese E. MiRNA: small molecules as potential novel biomarkers in cancer. Curr. Med. Chem. 2010, 17:4427-4432.
26. Dornan D., Settleman J. Cancer: miRNA addiction - depending on life's little things. Curr. Biol. 2011, 20:R812-813.
27. Rushworth S.A. Targeting the oncogenic role of miRNA in human cancer using naturally occurring compounds. Br. J. Pharmacol. 2011, 162:346-348.
28. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentleman R., Vessella R.L., Nelson P.S., Martin D.B., Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105:10513-10518.
29. Zhai H., Ju J. Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics. Front Genet. 2011, 2:78-89.
30. Li L.N., Zhang H.D., Zhi R., Yuan S.J. Down-regulation of some miRNAs by degrading their precursors contributes to anti-cancer effect of mistletoe lectin-I. Br. J. Pharmacol. 2011, 162:349-364.
31. van Hengel J., D'Hooge P., Hooghe B., Wu X., Libbrecht L., De Vos R., Quondamatteo F., Klempt M., Brakebusch C., van Roy F. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver. Gastroenterology 2008, 134:781-792.
32. Jung I.D., Lee J., Yun S.Y., Park C.G., Choi W.S., Lee H.W., Choi O.H., Han J.W., Lee H.Y. Cdc42 and Rac1 are necessary for autotaxin-induced tumor cell motility in A2058 melanoma cells. FEBS Lett. 2002, 532:351-356.
33. Papakonstanti E.A., Stournaras C. Tumor necrosis factor-alpha promotes survival of opossum kidney cells via Cdc42-induced phospholipase C-gamma1 activation and actin filament redistribution. Mol. Biol. Cell 2004, 15:1273-1286.